CORD-19:a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe / 15956-16164 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe","sourcedb":"CORD-19","sourceid":"a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe","text":"The data shown in Figure 5 demonstrate that transgenic overexpression of CCL2 in the CNS results in earlier onset of paralytic disease and more severe paralysis during the first 35 days of the disease course.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T97","span":{"begin":0,"end":208},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T97","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T97","span":{"begin":0,"end":208},"obj":"Sentence"}],"attributes":[{"subj":"T97","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T12","span":{"begin":151,"end":160},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0003470"},{"subj":"T12","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T95","span":{"begin":85,"end":88},"obj":"Body_part"}],"attributes":[{"id":"A95","pred":"uberon_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"subj":"T95","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93adec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#c7ec93"},{"id":"CORD-19-PD-HP","color":"#ec93e1"},{"id":"CORD-19-PD-UBERON","color":"#93ecdd"}]}]}}